Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2423 (LINC02423)
- Target
- LINC02423
- Molecular classification
- Long noncoding RNA, Long intergenic noncoding RNA, Other (does not belong to canonical families like receptor, enzyme, transporter)
01
Overview
Long intergenic non-protein coding RNA 2423 (LINC02423) is a member of the long noncoding RNA (lncRNA) family, specifically those transcribed from intergenic regions and not overlapping with protein-coding genes[7]. LincRNAs generally act as regulators of gene expression at the transcriptional and post-transcriptional levels, often modulating pathways related to cell differentiation, proliferation, and disease processes[3]. While the specific biological and clinical roles of LINC02423 are not well characterized in current literature, other lincRNAs have been implicated in cancer, autoimmune disease, and neurodevelopmental processes[3][7]. LINC02423 does not have established roles as a therapeutic target, nor are there drugs or diagnostic tests directly targeting it; its future significance will depend on upcoming molecular and clinical studies.
- Other names
- LINC02423
02
Mechanism of action
None defined (no drugs target LINC02423; mechanism would be via gene expression modulation if targeted[7])
03
Biological functions
Gene expression regulation (inferred from the role of lincRNAs generally[3][7])Possibly involved in cell cycle, apoptosis, cell adhesion, or immune response, by analogy to other lincRNAs[3][7]
04
Disease associations
Potential role in cancer (lincRNAs implicated broadly in cancer biology[7])Potential role in autoimmune disease or neurodegeneration (analogous to other lincRNAs[3])Other (no direct evidence for LINC02423-specific roles)
05
Safety considerations
None defined; general therapeutic challenges of targeting lncRNAs include specificity and delivery[3][7]
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2423 (LINC02423).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2423 (LINC02423).